SIRT3 Facilitates Amniotic Fluid Stem Cells to Repair Diabetic Nephropathy Through Protecting Mitochondrial Homeostasis by Modulation of Mitophagy
Conclusion: Collectively, our results demonstrate that AFSCs may be a promising therapeutic treatment for ameliorating diabetes and the development of diabetic nephropathy and that the overexpression of SIRT3 in AFSCs may further increase the efficiency of stem cell-based therapy.Cell Physiol Biochem 2018;46:1508 –1524
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cytology | Diabetes | Endocrinology | Gastroschisis Repair | Insulin | Kidney Transplant | Kidney Transplantation | Physiology | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology